As weight gain appears to be a side-effect of inhibitors of IL-6 signaling, they may be a potential pharmacological adjunct for the treatment of cancer cachexia and anorexia nervosa
As weight gain appears to be a side-effect of inhibitors of IL-6 signaling, they may be a potential pharmacological adjunct for the treatment of cancer cachexia and anorexia nervosa. the IL-6 pathway is usually involved in weight regulation. Modulating IL-6 signaling may be a potential future therapeutic avenue used as an adjunct for the treatment […]